Image

Kristjan Bloudoff

Associate

Kristjan advises on a wide range of intellectual property matters, with a particular focus on patent litigation. 

His experience covers various technical areas, including life sciences, telecommunications, and other technologies.

Before moving into law, Kristjan was awarded a PhD in biochemistry, allowing him a deep technical understanding of complex cases whilst being able to deliver practical strategic and commercial advice to clients.

Experience

Pro bono

Assisting an international children's charity in researching international and regional legal frameworks that set benchmarks for progress in education, as well as the forums that monitor and support progress in education.

Published Work

  • Bloudoff K and Schmeing TM (2017), “Structural and functional aspects of the nonribosomal peptide synthetase condensation domain superfamily: discovery, dissection and diversity”, Biochimica et Biophysica Acta - Proteins and Proteomics, 1865(11 Pt B):1587-1604.
  • Bloudoff K, Fage CD, Marahiel MA, and Schmeing TM (2017), “Structural and mutational analyses of the nonribosomal peptide synthetase heterocyclization domain provide insight into catalysis”, Proceedings of the National Academy of Sciences, 114(1): 95-100.
  • Bloudoff K, Alonzo DA, and Schmeing TM (2016), “Chemical Probes Allow Structural Insight into the Condensation Reaction of Nonribosomal Peptide Synthetases”, Cell Chemical Biology, 23(3):331-339.
  • Bloudoff K, Rodionov D, and Schmeing TM (2013), “Crystal structures of the first condensation domain of CDA synthetase suggest conformational changes during the synthetic cycle of nonribosomal peptide synthetases”, Journal of Molecular Biology, 425(17): 3137–3150.

Qualifications

Admissions

England and Wales, 2021

Academic

PhD, Biochemistry, McGill University, 2017

BMSc, Biochemistry, University of Western Ontario, 2010

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.